At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Periarticular Multimodal Drug Injections in Total Knee Arthroplasty
In Brief
A Phase 4 clinical trial evaluating ropivacaine, morphine sulfate, and 3 other interventions for Osteoarthritis, Knee. Completed, enrolled 101 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether periarticular multimodal drug injection (PMDI) would provide additional benefits in patients after total knee arthroplasty (TKA) for whom contemporary pain control protocols using the continuous femoral nerve block, intra-venous patient controlled analgesia (IV-PCA)and preemptive oral medications. We hypothesized that PMDI would reduce pain level and consumption of PCA and acute pain rescuer and would provide better functional recovery and patient satisfaction. We also hypothesized that the incidence of side effects and complications of the PMDI would be similar to the No-PMDI.
Study Details
Timeline
Interventions
300mg (0.75%, 40cc) intraoperative periarticular injection
10mg intraoperative periarticular injection
30 mg intraoperative periarticular injection
300 microgram (1:1000) intraoperative periarticular injection
750mg intraoperative periarticular injection